Free Trial

Stock Price Targets and Analyst Ratings

CompanyActionBrokerageAnalystCurrent PricePrice TargetRatingDetails
Aclaris Therapeutics, Inc. stock logo
ACRS
Aclaris Therapeutics
Upgraded byHC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$2.89
+6.3%
$20.00 ➝ $20.00Neutral ➝ Buy
CAE Inc. stock logo
CAE
CAE
Upgraded byDesjardins
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$24.55
+3.3%
Hold ➝ Buy
GCM Grosvenor Inc. stock logo
GCMG
GCM Grosvenor
Upgraded byPiper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$12.14
+3.3%
$12.50 ➝ $14.00Neutral ➝ Overweight
PotlatchDeltic Co. stock logo
PCH
PotlatchDeltic
Upgraded byRaymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$39.58
+2.1%
$45.00Market Perform ➝ Outperform
Weyerhaeuser stock logo
WY
Weyerhaeuser
Upgraded byRaymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
$28.08
+2.1%
$32.00Market Perform ➝ Outperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 10:46 PM ET.